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STUDIES OF HYPOXEMIC/ 
REOXYGENATION INJURY 
WITH AORTIC CLAMPING: 
XI. Cardiac advantages of 
normoxemic versus 
hyperoxemic management 
during cardiopulmonary 
bypass 
The conventional Way to start cardiopulmonary bypass is to prime the 
cardiopulmonary bypass circuit with hyperoxemic blood (oxygen tension 
about 400 mm Hg) and deliver cardioplegic solutions at similar 6xygen 
tension levels. This study tests the hypothesis that an initial normoxemic 
oxygen tension strategy to decrease the oxygen tension-dependent ra e of 
oxygen free radical production will, in concert with normoxemic blood 
cardioplegia, limit reoxygenation damage and make subsequent hyperox- 
emia (oxygen tension about 400 mm Hg) safer. Thirty-five immature (3 to 
5 kg, 2 to 3 week old) piglets underwent 60 minutes of cardiopulmonary 
bypass. Eleven control studies at conventional hyperoxemic oxygen tension 
(about 400 mm Hg) included six piglets that also underwent 30 minutes of 
blood cardioplegic arrest. Of 25 studies in which piglets were subjected to up 
to 120 minutes of ventilator hypoxemia (reducing fraction of inspired oxygen to 
5% to 7%; oxygen tension about 25 mE Hg), 11 underwent either abrupt 
(oxygen tension about 400 mm Hg, n = 6) or gradual (increasing oxygen 
tension from 100 to 400 mm Hg over a 1-hour period, n = 5) reoxygenation 
without blood cardioplegia. Fourteen others underwent 30 minutes of blood 
cardioplegic arrest during cardiopulmonary bypass. Of these, nine were 
reoxygenated at oxygen tension about 400 mm Hg, and five others underwent 
nonnoxemic cardiopulmonary b pass and blood cardioplegia (oxygen tension 
about 100 mmHg) with systemic oxygen tension raised to 400 mm Hg after 
aortic unclamping. Measurements of lipid peroxidation (conjugated ienes 
and antioxidant reserve capacity) and contractile function (pressure-volume 
loops, conductance catheter, end-systolic elastance) were made before and 
during hypoxemia nd 30 minutes after reoxygenation. Hyperoxemic cardio- 
pulmonary bypass did not produce oxidant damage or reduce functional 
recovery after cardiopulmonary b pass in nonhypoxemic controls. In contrast, 
abrupt and gradual reoxygenation without blood cardioplegia produced signif- 
icant lipid peroxidation (84% increase in conjungated dienes), lowered antiox- 
idant reserve capacity 68% -+ 5%, 44% --- 8%, respectively, and decreased 
functional recovery 75% -+ 6% (p < 0.05), 66% - 4% (p < 0.05). Similar 
impairment followed abrupt reoxygenation before blood cardioplegic myocar- 
dial management, because conjungated iene production increased 13-fold, 
antioxidant reserve capacity fell 40%, and contractility recovered only 21% -+ 
2% (p < 0.05). Conversely, normoxemic nduction of eardiopulmonary b pass 
and blood cardioplegic myocardial management reduced conjungated iene 
production 73%, avoided impairment of antioxidant reserve capacity, and 
resulted in 58% - 11% recovery of contractile function. We conclude that these 
data suggest hat reoxygenafion damage is (1) oxygen tension dependent, 
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(2) occurs whether reoxygenation is abrupt or gradual in the absence of blood 
cardioplegia, and (3) can be reduced by normoxemic management when CPB is 
started and during blood cardioplegic administration before subsequent reintroduc- 
tion of hyperoxemia. (J THO~C CARDIOVASC SURG 1995;110:1255-64) 
R eintroduction of molecular oxygen in hypoxemic hearts during initiation of cardiopulmonary b - 
pass (CPB) produces a reoxygenation i jury 1-4 that 
may nullify an otherwise safe myocardial manage- 
ment technique of blood cardioplegia during aortic 
clamping.5, 6 The role of oxygen free radicals in this 
process is reinforced by studies howing that antiox- 
idant interventions that interfere with relevant path- 
ways of oxygen-mediated damage z'7-9 reduce lipid 
peroxidation, enzyme release 3'9-I2 and improve 
functional recovery after CPB. 
The conventional way to start CPB is to produce 
hyperoxemia by mixing the patient's blood with ~he 
extracorporeal circuit primed at oxygen tension 
(Po2) about 400 mm Hg despite in vitro evidence of 
the Poz-dependent nature of reoxygenation dam- 
age,11, 13, 14 and in vivo findings that initial hyperox- 
emic CPB may produce damage before aortic 
clamping is imposed for surgical correction, e' 15, 16 
We consider eoxygenation damage a biologic phe- 
nomenon that may affect other organs, because lung 
opacification follows hyperoxemic extracorporeal 
membrane oxygenation i cyanotic infants with pul- 
monary disorders 17 and causes myocardial dysfunc- 
tion,iS, 19 and reduced Po 2 during reoxygenation is 
neuroprotective to chronically hypoxemic neuronal 
cells, z° This latter observation, coupled with the 
Poz-dependent extent of myocardial damage during 
reoxygenation, 13 led tO the current study that applies 
a similar strategy to hypoxemic immature hearts 
reoxygenated on CPB. Our findings confirm the 
occurrence of reoxygenation injury and show (1) it is 
not avoided by only slowing the rate of reoxygen- 
ation, and (2) its nullification of the cardioprotective 
effects of blood cardioplegic myocardial manage- 
ment can be limited by starting CPB and delivering 
blood cardioplegia t normoxemic (Po 2 about 100 
mm Hg) levels before raising Po 2 to about 400 mm 
Hg, the conventional CPB management method. 
Material and methods 
Experimental model. Thirty-five immature, 2- to 3-week- 
old Duroc-Yorkshire piglets (3 to 5 kg) were premedicated 
with 0.5 mg/kg diazepam intramuscularly, anesthetized with 
30 mg/kg pentobarbital intraperitoneally followed by 5 mg/kg 
intravenously each hour, and the lungs ventilated on a 
volume-limited respirator (Servo 900D, Siemens-Elema, 
Solna, Sweden) via a tracheostomy. All animals received 
humane care in compliance with the "Principles of Labora- 
tory Animal Care" formulated by the National Society for 
Medical Research and the "Guide for the Care and Use of 
Laboratory Animals" prepared by the National Academy of 
Sciences, published by the National Institutes of Health 
(NIH Publication No. 86-23, revised 1985). 
The surgical preparation, including vessel cannulation 
for CPB and catheter placement for monitoring and blood 
sampling, is similar to that reported previously) 
Physiologic and biochemical determinations. Arterial 
blood gas, electrolyte, and hemoglobin measurements 
were made every 15 minutes and analyzed by a blood gas 
system (Blood Gas System 288, Ciba-Corning, Medfield, 
Mass.). Left ventricular (LV) performance was evaluated 
by inscribing end-systolic pressure volume relationship 
with a LV five-electrode conductance catheter with a 
distance of 4 mm between electrodes (Webster Laborato- 
ries, Baldwin Park, Calif.), inserted through the LV apex, 
connected to a Sigma 5-DF Signal Conditioner Processor 
(Leycom, Oegstgeest, The Netherlands). A series of de- 
clining LV pressure-dimension l ops were obtained by 
inferior vena cava occlusion during a 7-second apnea 
period as described previously. End-systolic pressure vol- 
ume relationship was analyzed by an interactive video- 
graphics data analysis computer program (Spectrum 21) on 
a 386/33 MHz IBM computer (IBM, Armonk, N.Y.), and 
LV performance was described as the slope of linear 
regression (end-systolic elastance [Ees]), as described 
previously. P0stbypass LV contractility was assessed by 
percent recovery of prebypass control value (percent Ees). 
Data were expressed as Ees. 
Myocardial oxidant injury 
Conjugated diene. Plasma conjugated dienes (CD) lev- 
els were measured in 0.5 ml plasma samples of arterial 
and coronary sinus blood to determine lipid peroxidation 
by the method of Lesnefsky and coworkers 22 as discussed 
previously. Myocardial CD production was determined in 
studies in which blood cardioplegia was delivered from the 
following equation: CD production = CBF × V - A, 
where CBF is the cardioplegic flow rate delivered by 
calibrated roller pump and A and V are arterial and 
coronary sinus CDs. 
Antioxidant reserve capacity. Cardiac vulnerability to 
oxidant stress was evaluated by incubating myocardial 
homogenates in varying concentrations (1 to 4 retool/L) of 
the oxidant t-butylhydroperoxide andmeasuring malondi- 
aldehyde lution by the method of Godin et al. 2a as 
previously described. 
Hemodynamics. Measurements of cardiac output (ther- 
modilution), arterial pressure, and left atrial pressure 
were made before the start of hypoxemia (control), each 
15 minutes during hypoxemia, nd 15 and 30 minutes after 
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CPB was discontinued. Measurements were used to cal- 
culate left ventricular stroke work index as described 
previously.i, 24 At the conclusion of each experiment each 
heart was examined postmortem to ensure closure of the 
ductus arteriosus and foramen ovale. 
Experimental groups 
Nonhypoxemic studies. Eleven piglets underwent 60 
minutes of CPB at Po2 about 400 mm Hg. Six underwent 
30 minutes of blood cardioplegic arrest according to the 
following protocol: after 5 minutes of CPB, they under- 
went 30 minutes of aortic clamping with a hyperoxemic 
blood cardioplegic solution that was developed experi- 
mentally 2527 and is usedclinically. 2s' 29 The blood car- 
dioplegic management protocol included warm cardiople- 
gia (37 ° C) for 3 minutes followed by cold cardioplegia for 
2 minutes (4 ° C) and a 3-minute warm infusion just before 
aortic unclamping. Infusion rate was regulated initially by 
a calibrated pump at 10 ml/min/kg to produce arrest and 
5 ml/min/kg thereafter with aortic pressure averaging 
about 50 mm Hg. CPB was discontinued 25 minutes after 
aortic unclamping, and functional and biochemical mea- 
surement were made 30 minutes later. 
Hypoxemia on CPB studies. Twenty-four piglets under- 
went up to 2 hours of hypoxemia by reducing ventilator 
fraction of inspired oxygen (Fio2) to 6% to 7% to lower 
arterial Po2 to about 25 mm Hg. Extracorporeal circula- 
tion was started before 120 minutes if mean arterial 
pressure could not be kept above 30 mm Hg by volume 
infusion or pH above 7.3 by up to three bolus injections of 
sodium bicarbonate. 
REOXYGENATION WITHOUT CPB 
1. Abrupt hyperoxemic reoxygenation. Five piglets under- 
went reoxygenation byinitiating CPB at Po 2 about 400 
mm Hg and did not undergo aortic clamping. 
2. Gradual reoxygenation. I  five other piglets, CPB was 
started at Po2 about 100 mm Hg, and Po2 was raised to 
about 400 mm Hg by 100 mm Hg increments each 15 
minutes during the 60 minutes of CPB. No piglet 
underwent an interval of aortic clamping. 
REOXYGENATION WITH CPB STUDIES 
In 14 piglets the aorta was clamped 5 minutes after the 
start of CPB using the blood cardioplegia management 
protocol described previously with the following Po2 
management method. 
1. Hyperoxemic management. In nine piglets, CPB was 
started at Po2 about 400 mm Hg, and blood cardiople- 
gia was delivered at the same Po2. 
2. Normoxemic management. In five piglets CPB was 
started at P% about 100 mm Hg (as described previ- 
ously), and P% was maintained at 100 mm Hg in the 
blood cardioplegic management protocol. 
In all piglets Po2 was raised to 400 mm Hg immediately 
after aortic unclamping and kept at that level for the 
remainder of the study. Final hemodynamic and blood 
measurements were made 30 minutes after the discontin- 
uation of bypass, after which myocardial biopsy samples 
were obtained for subsequent analyses. 
Statistics. Data were analyzed with the use of the 
StatView V2.0 program (Abacus Concepts Inc., Berkeley, 
Endsystolic Elastance (% Ees) 
Abrupt vs. Gradual ReO2 
% 
control 
Ees 
100 
80 
60 
40 
20 
0 
. p<O.O5 vs. control 
Abrupt Gradual 
Reoxygenat ion  1" 
1" No Blood Cardioplegia 
Fig. 1. Percent recovery of LV Ees after abrupt or grad- 
ual reoxygenation without blood cardioplegia (see text for 
description). 
Calif.) on a Macintosh IIci computer (Apple, Inc., Cuper- 
tino, Calif.). Analysis of variance was used for intergroup 
comparison, and the paired Student test was used for 
comparison of variables within experimental groups. The 
relationship between functional impairment (percent Ees) 
and lipid peroxidation (CDs) was tested by linear regres- 
sion analysis. Differences were considered significant at 
the probability level of p < 0.05. Group data were 
expressed as mean plus or minus standard error of the 
mean. 
Results 
Systemic hemodynamics are shown in the Table 
and remained unchanged from control levels in 
nonhypoxemic piglets who underwent 60 minutes of 
CPB with or without 30 minutes of blood cardiople- 
gic arrest. Hypoxemia produced tachycardia (heart 
rate rose from 170 +_ 10 to 206 _+ 15 beats/min) and 
initial increase in cardiac output (35% _+ 8% at 30 
minutes) and systemic vasodilation (systemic vascu- 
lar resistance fell 34% _+ 12%) and pulmonary 
vasoconstriction (pulmonary vascular resistance 
rose 120% _+ 12%). Hemodynamic deterioration 
occurred in all piglets after approximately 60 min- 
utes of hypoxemia requiring initiation of CPB be- 
fore 2 hours in 17 of 24 piglets. The average 
hypoxemic duration was 78 _+ 12 minutes, with a 
comparable number of piglets in each group need- 
ing premature CPB before 120 minutes. 
Recovery of LV contractility (Ees) was complete 
in all nonhypoxemic control studies of piglets sub- 
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Table. Hemodynamic measurements 
Control ReO 2 without BCP ReO 2 + BCP 
Variable CPB BCP Abrupt Gradual Po 2 -400 Po 2 ~100 
Hypoxia (rain) - -  - -  84 22 9 60 ± 
ReO 2 <120 min - -  - -  3/5 4/5 
Mean aortic pressure (mm Hg) 
Control  70 _+ 5 52 ± 5 69 ± 5 50 ± 
End hypoxia - -  - -  47 ± 6 50 _+ 
30 min after CPB 59 ± 4 49 _+ 4 51 _+ 5 56 ± 
Heart  rate (beats/rain) 
Control  170 _+ 10 166 -- 9 170 ± 8 178 ± 
End hypoxia - -  - -  176 ± 7 173 ± 
30 rain after CPB 205 _+ 15 205 _+ 10 163 22 8 170 _+ 
Cardiac index (ml/min/kg) 
Control  114 _+ 18 74 _+ 19 119 ± 9 129 ± 
End hypoxia - -  - -  93 _+ 11 55 ± 
30 min after CPB 82 _+ 8 64 22 4 65 -+ 7* 107 ± 
SVRI  (mm Hg.  C -1 • kg) 
Control  676 ± 117 634 ± 84 616 ± 13 455 _+ 
End hypoxia - -  - -  482 _+ 50 356 _+ 
30 rain after CPB 729 + 55 828 ± 125 685 ± 98 513 _+ 
PVRI  (ram Hg.  min .  L -1 . kg) 
Control  88 ± 13 101 ± 23 117 ± 32 92 22 
30 min after CPB 207 ± 30 212 _+ 32 296 ± 34* 205 ± 
7 75 + 8 65 -- 5 
6/9 4/5 
3 63226 50222 
12 44 -+ 7 39 -+ 8 
14 41 -+ 4* 45 ± 8 
13 202 ± 5 184 ± 5 
15 184 ± 18 170 ± 12 
12 196 ± 20 176 ± 13 
15 118±6 98-+ 16 
15' 79 ± 19" 38 -+ 26* 
20 85 + 11 75 + 9 
82 537 -+ 44 559 -+ 82 
117 348 -+ 62 444 -+ 79 
82 571 -- 89 715 ± 89 
12 72 -+ 8 107 -+ 22 
48 312 -+ 53* 177 + 13 
BCP, Blood cardioplegia; ReO2, reoxygenation; control, no hypoxia; SVR/, systemic vascular index; PVR/, pulmonary vascular resistance index. 
*p < 0.05 vs control. 
jected to 60 minutes of CPB at Po 2 about 400 mm 
Hg with or without 30 minutes of aortic clamping 
with the blood cardioplegic myocardial management 
protocol. In contrast, recovery of Ees was 25% + 
5% after abrupt hyperoxemic reoxygenation and 
was not improved appreciably (34% _+ 4% recovery 
of Ees) when Po2 was raised from 100 mm Hg to 400 
mm Hg gradually during the 60 minutes interval of 
CPB (p < 0.05 vs control, Fig. 1). 
Initial hyperoxemic CPB negated the cardiopro- 
tective effects of blood cardioplegia, because Ees 
recovered only 21% + 2% (Fig. 2) in piglets sub- 
jected to 30 minutes of aortic clamping after CPB 
was started at Po 2 about 400 mm Hg. Improved LV 
recovery occurred when Po 2 was kept at normox- 
emic levels (Po 2 about 100 mm Hg) during both 
initiation of CPB and while blood cardioplegia was 
delivered, as Ees returned to 58% _+ 11% of pre- 
hypoxemic levels (Po2 < 0.05 vs abrupt and gradual 
reoxygenation r hyperoxemic CPB and blood car- 
dioplegia). However, final values for Ees did not 
return to prehypoxemic levels, and remained lower 
than after hyperoxemic CPB (with and without 
blood cardioplegia) in piglets that did not/mdergo 
pre-CPB hypoxemia. 
Biochemical. Hyperoxemic CPB without preced- 
ing hypoxemia did not cause myocardial lipid per- 
oxidation or reduce cardiac antioxidant reserve ca- 
pacity, because no CDs were produced either during 
induction or reperfusion during the 30-minute 
interval of aortic clamping, and antioxidant re- 
serve capacity was unchanged from control values 
after the 30-minute observation period after CPB. 
Myocardial cardiac CD production was evaluated 
only in piglets receiving blood cardioplegia, be- 
cause coronary flow was known from the car- 
dioplegic flow rate. Hyperoxemic blood cardiople- 
gia caused a 12-fold increase in CD production 
compared with nonhypoxemic controls (Fig. 3, A), 
and this was reduced by 73% when normoxemic 
strategy was used to start CPB and deliver blood 
cardioplegia in previously hypoxemic piglets. 
Myocardial CD production persisted throughout 
the aortic clamping interval in hearts managed by 
the hyperoxemic strategy, while no significant 
lipid peroxidation was evident during reperfusion 
when the blood cardioplegic solution was kept 
normoxemic (Fig. 3, B). Signs of lipid peroxida- 
tion continued after aortic unclamping after hy- 
peroxemic reoxygenation, because coronary sinus 
CDs remained increased (Fig. 4) and did not 
return to control levels until CPB was discontin- 
ued. Conversely, CD levels fell to control levels 
during reperfusion after normoxemic manage- 
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Fig. 2. Percent recovery of LV Ees in nonhypoxemic piglets undergoing hyperoxemic blood cardioplegia 
(Po2) about 400 mm Hg and after reoxygenation f hypoxemic piglets with either normoxernic (Po2 about 
100 mm Hg) or hyperoxemic (Po2 about 400 mm Hg) blood cardioplegic solution (see text for description). 
ment and coronary sinus CDs did not increase 
after aortic unclamping. 
Hyperoxemic reoxygenation produced a 40% re- 
duction in antioxidant reserve when myocardial homo- 
genates were incubated in the oxidant -butylhydroper- 
oxide (Fig. 5), whereas this impairment of antioxidant 
reserve capacity did not occur after the normoxemic 
reoxygenation strategy managing CPB and blood car- 
dioplegia. 
Discuss ion 
This in vivo study of hypoxemia/reoxygenation in 
the immature piglet provides data to suggest hat 
conventional clinical methods of starting CPB at 
high Po 2 produces cardiac reoxygenation damage 
that nullifies the cardioprotective effects of an oth- 
erwise safe myocardial management technique of 
blood cardioplegia. 5' 6 New information includes the 
finding that (1) the signs of lipid peroxidation, 
impaired antioxidant reserve capacity, and contrac- 
tile recovery that follow abrupt reoxygenation are 
not avoided by more gradual reoxygenation (i.e., 
over 1 hour), (2) a blood cardioplegic strategy that is 
safe in immature porcine hearts 5 and that limits 
reperfusion damage is rendered ineffective by a brief 
(i.e., 5 minutes) interval of hyperoxemic reoxygen- 
ation, and (3) damage may be limited substantially 
by using a normoxemic Po 2 management s rategy 
during initiation of CPB and blood cardioplegia 
delivery before raising Po2 to the conventional hy- 
peroxemic levels used during most cardiac opera- 
tions on immature and adult hearts. Studies were 
terminated 30 minutes after CPB, so that the exper- 
imental design precluded assessment of reversibility 
or progression of the observed changes. 
The role of oxidant damage in the genesis of 
biochemical and functional impairment after reoxy- 
genation in this study seemed independent of the 
effects of CPB per se, because hyperoxemic CPB 
and blood cardioplegia did not produce CD produc- 
tion (the selected marker for lipid peroxidation), 
reduce antioxidant reserve capacity (the bioassay 
marker of endogenous antioxidant levels), or impair 
contractile recovery. Our findings of reoxygenation 
damage in the in vivo piglet model (which parallels 
more closely the human condition 3°) are consistent 
with the in vitro findings that: (1) hypoxemia depletes 
endogenous antioxidants, 1°' 31 which become further 
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Fig. 3. Myocardial CD production during cardioplegic induction and reperfusion in control piglets 
undergoing hyperoxemic (Po 2 400 mm Hg) CPB and blood cardioplegia nd in hypoxemic piglets 
reoxygenated with either normoxemic (Po 2 100 mm Hg) or hyperoxemic (Po 2 400 mm Hg) blood 
cardioplegic solution (see text for description). 
exhausted with reoxygenation, 31 and (2) a burst of 
oxygen free radicals follows reoxygenation that is 
associated with signs of lipid peroxidation is linked to 
enzyme release, ultrastructural damage, 1°' 11 and func- 
12 tional depression. Our data suggest that the impaired 
antioxidant reserve capacity that follows either abrupt 
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Fig. 4. CD concentration i coronary sinus blood sampled uring hypoxemia nd reoxygenation with 
cardioplegia (BCP) on CPB. Control piglets did not undergo hypoxemia or reoxygenation, and hypoxemic 
piglets were reoxygenated with either normoxemic (Po 2 100 mm Hg) or hyperoxemic (P02 400 mm Hg) 
blood cardioplegic solution (see text for description). 
or gradual reoxygenation renders the previously hy- 
poxemic myocardium ore vulnerable to ischemic/ 
reperfusion damage during aortic clamping, as shown 
by Silverman and coworkers 32 and Fujiwawa and col- 
leagues. 33 
The Po2-dependent ature of this damage can be 
inferred from the experimental studies of Hearse 
and coworkers, 13 the clinical reports of isolated 
myocytes in patients with tetralogy of Fallot, 34 as 
well as evidence that abrupt reoxygenation depletes 
16 endogenous antioxidants, in cyanotic patients even 
before aortic clamping is imposed. Hyperoxemic 
reoxygenation exaggerates the biochemical and 
structural adverse consequences of reintroduction 
of molecular oxygen in in vivo studies, 13 whereas the 
damage is diminished by supplementation f the 
extracorporeal circuit primed with either antioxi- 
2 79  .~5 dants ' - ' ~ that limit the classic Haber-Weiss path- 
way of oxygen-mediated damage or substances that 
interfere with the more recently recognized I.-argi- 
nine-nitric oxide (.NO) pathway. 2'36 
The aforementioned observations led to the cur- 
rent study of normoxemic management, especially 
because the maximum velocity (Vm~,) for "NO syn- 
thase is Poa-dependent and recent studies how that 
gradual reoxygenation is neuroprotective in chroni- 
cally hypoxemic neuronal cells. 2° Our decision to pro- 
ceed with a normoxemic strategy is in part based on 
recognition that hyperoxemic reoxygenation confers a 
negligible increase in oxygen content, because blood 
oxygen content is related primarily to hemoglobin 
content. Oxygen saturation is approximately 99% at 
Po 2 about 100 mm Hg so that potential cytotoxic 
effects of raising P02 to 400 mm Hg may overcome the 
almost imperceptible r duction in oxygen delivery of 
using a normoxemic approach. The hyperoxemic man- 
agement method imposed uring the latter phase of 
CPB and the post-CPB period and may have biased 
results unfavorably. 
The failure to reduce damage by gradual re0xy- 
genation without blood cardioplegia suggests that 
modification of P02 levels alone is an insufficient 
method of offsetting reoxygenation i jury if hyper- 
oxemia is allowed to occur. Normoxemia during 
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Fig. 5. Myocardial ntioxidant reserve capacity incontrol piglets undergoing hyperoxemic CPB and blood 
cardioplegia without hypoxemia (control) and hypoxemic piglets undergoing reoxygenation with either 
hyperoxemic (Po 2 400 rnm Hg), or normoxemic (Po 2 100 mm Hg) blood cardioplegic solution (see text for 
description). 
induction of CPB and blood cardioplegia was ben- 
eficial but did not avoid reoxygenation damage 
completely when followed by hyperoxemia; mild 
lipid peroxidation was evident and function recov- 
ered only 60% after the use of a cardioplegic 
strategy that allowed complete recovery in nonhy- 
poxemic hearts despite hyperoxemia. 
The effectivenesS ofnormoxemic CPB with blood 
cardioplegia strategy was evident in the more exten- 
sive damage that followed gradual reoxygenation in 
the absence of surgical ischemia with blood cardio- 
plegia. We ascribe the salutary effects of blood 
cardioplegia to (1) replenishment of amino acids 
depleted uring hypoxemia, 37 (2) limited calcium 
loading during reoxygenation 38 because dxygen radi- 
cal-induced cellular calcium overload and con- 
tractile abnormalities are reported recently in 
reoxygenated cardiac myocytes, 38' 39 and (3) re- 
duction in .NO overproduction, which can result 
in the toxic oxygen intermediate peroxynitrite 
(OONO-)  that degrades to "OH.  40 Further stud- 
ies are needed to define the roles of the other 
cardioplegic onstituents in limiting reoxygen- 
ation injury as well ag whether further reduction 
of Po2 during initiati6n of CPB and before reoxy- 
genation may provid6 added benefits when CPB 
and blood cardioplegia are used in the correction 
of congenital-causing cyanosis. 
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